FDA Approves Alcon’s BRYTLY Redness Relief Eye Drops

The FDA approved Alcon’s BRYTLY over-the-counter redness-relief eye drops, which provide relief for up to 12 hours. Retail availability nationwide and online is expected in the coming months. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alcon AG published the original content used to generate this news brief via (Ref. ID: 202610161557BIZWIRE_USPR_____20261016_BW454136) on October 16, 2026, and is solely responsible for the information contained therein. (C)